Benzinga | Apr 29, 2021 09:24AM EDT

BTIG Maintains Buy on Teladoc Health, Lowers Price Target to $300

BTIG analyst David Larsen maintains Teladoc Health (NYSE:TDOC) with a Buy and lowers the price target from $330 to $300.